The Mounjaro KwikPen: a step-by-step guide to your injection device

Each KwikPen holds four weekly doses — one pen lasts a full four-week treatment period.
The device is pre-filled and pre-set; no drawing up, no dial-in dose adjustment, no manual assembly.
Treatment begins at 2.5 mg and is titrated by your prescriber, typically stepping up every four weeks.
Suitable injection sites are the abdomen, thigh, or upper arm — rotating the site each week reduces skin reactions.

The Mounjaro KwikPen is a pre-filled, multi-dose pen device that delivers tirzepatide as a once-weekly subcutaneous injection. Each pen contains four weekly doses, comes ready to use with a concealed needle, and does not require manual assembly before injecting. It is a prescription-only medicine available in the UK in six strengths, from 2.5 mg up to 15 mg, and is licensed for weight management alongside a reduced-calorie diet and increased physical activity. Because tirzepatide is a prescription-only medicine, a prescriber assesses your suitability before any pen is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using your Mounjaro KwikPen safely: the process from first injection to last dose

Step 1: Before you inject, storage, checks and preparation

Your KwikPen arrives refrigerated and should be kept at 2–8 °C between uses. Many people keep the current pen in the fridge door, where the temperature is stable and it is easy to spot on injection day. The exact window for keeping a pen at room temperature once removed from the fridge is set out in the Mounjaro SmPC on the eMC, always check that document rather than relying on a summary, because the window is specific.

Before each injection, take the pen out of the fridge and allow it to reach room temperature for the time your prescriber or the patient information leaflet recommends. Check the liquid through the viewing window: it should be clear to slightly yellow and free of visible particles. If it looks cloudy, discoloured, or contains floating matter, do not use it. Check the expiry date printed on the label. Wash your hands thoroughly.

Clean the chosen skin site with an alcohol swab and let it dry completely before injecting, injecting through wet skin stings more and can affect absorption. You will need a new needle for each injection; the right needles for the KwikPen are a standard part of the kit to have ready.

Step 2: Attaching a needle and performing the injection

The KwikPen is designed to be straightforward, but the first injection often feels daunting. That is entirely normal, most people find the anxiety fades quickly once they have done it once or twice.

Attach a fresh needle by removing the paper tab, pressing the needle cap firmly onto the pen's cartridge end, and twisting clockwise until secure. Remove the outer needle cap (keep it for disposal) and then the inner cap. You do not need to prime the pen or expel air as you would a traditional insulin syringe.

Pinch the cleaned skin lightly or leave it flat depending on the injection site, then press the pen firmly against the skin until the needle is fully inserted. Press and hold the injection button until the dose counter returns to zero, then continue holding for a further ten seconds before removing. This pause ensures the full dose is delivered. A detailed visual walkthrough is available in the Mounjaro KwikPen injection video if you want to see each step before you begin.

For a thorough written guide covering every step (including what to do if the injection button is hard to press) see the how to take the Mounjaro KwikPen page.

Step 3: After the injection, disposal, records and side-effect awareness

Re-cap the needle immediately using the outer cap, then unscrew and remove it from the pen. Dispose of used needles directly into an approved sharps container, never into a household bin, where they pose a risk to others. The pen itself can be discarded in normal household waste once all four doses are used and the needle has been removed.

Note the date and injection site in a small diary or phone note. Rotating the site systematically (abdomen one week, thigh the next) helps avoid lipohypertrophy (hardened patches under the skin that can reduce absorption). The Mounjaro injection guide covers site rotation in more detail.

The most common side effects after injecting are gastrointestinal: nausea, loose stools, indigestion, or reduced appetite. These are most pronounced after the first injection at a new dose and tend to settle over the following days. According to NHS guidance on tirzepatide, if you experience severe, persistent stomach pain that radiates to the back, seek urgent medical help as this can be a sign of pancreatitis. Contact your prescriber or our support team with any concerns between doses. Report unexpected side effects via the MHRA's Yellow Card scheme.

What the KwikPen does not do, and what that means for your treatment

The KwikPen delivers a fixed dose every time. You cannot adjust the amount per injection, skip part of a dose, or top up if you think something went wrong. If you press the button and the counter does not reach zero, or if the pen leaked, do not inject again to compensate, contact your prescriber.

Each pen is set to a single strength. If your prescriber increases your dose, you will receive a new pen at the higher strength; the changeover is a clinical decision, not a self-managed one. Guidance on switching between KwikPen strengths explains what to expect at each stage of titration.

The KwikPen also does not need priming and has no cartridge to replace. Its simplicity is deliberate. Understanding what the device is designed to do (and what falls outside its scope) makes each weekly injection more straightforward and keeps your treatment on track. If you are ready to explore whether tirzepatide is clinically suitable for you, our prescribers are available through the free consultation page.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions